Text Size
1696 studies found for:    Uterine Diseases: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Uterine Diseases: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results 		Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors
Conditions: Primary Peritoneal Carcinoma;   Tumor;   Epithelial Ovarian Cancer;   Uterine Disease;   Cervix Diseases;   Neoplasms, Ovarian;   Cancer
Interventions: Drug: pazopanib (GW786034);   Drug: carboplatin;   Drug: paclitaxel
2 Completed Deep Dive Randomized Control Trial
Conditions: Chronic Disease;   Arthritis;   Uterine Diseases;   Spinal Diseases;   Preventive Health Services
Interventions: Behavioral: Enhanced Support;   Behavioral: Usual-Support
3 Recruiting Study of Laparoendoscopic Single Site Hysterectomy in Benign and Preinvasive Uterine Disease
Condition: Benign or Preinvasive Uterine Disease
Interventions: Procedure: Single-port LAVH;   Procedure: Three-port LAVH
4 Recruiting A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Conditions: Solid Tumors and Advanced Endometrial Cancer;   Endometrial Cancer;   Second-line Treatment;   VEGF
Intervention: Drug: TKI258
5 Completed Soy Estrogen Alternative Study (SEA)
Conditions: Cardiovascular Diseases;   Endometrial Hyperplasia;   Heart Diseases;   Menopausal Complaints;   Uterine Diseases;   Menopause
Interventions: Drug: estrogens, conjugated;   Behavioral: diet, soy proteins;   Behavioral: dietary supplements
6 Recruiting Study on Bladder and Sexual Function Change After Simple Hysterectomy
Condition: Benign Uterine Disease
Intervention:
7 Active, not recruiting Feasibility of a Trial of Laparoscopic Hysterectomy Versus Laparoscopic Sub-Total Hysterectomy
Condition: Benign Disease of the Uterus
Interventions: Procedure: Laparoscopic Hysterectomy;   Procedure: Laparoscopic Supracervical Hysterectomy
8 Unknown † Single-port Access Laparoscopic-assisted Vaginal Hysterectomy
Conditions: Uterine Myomas;   Adenomyosis
Intervention: Procedure: single-port LAVH
9 Completed BGS649 Monotherapy in Moderate to Severe Endometriosis Patients
Condition: Endometriosis
Interventions: Drug: BGS649;   Drug: Placebo
10 Completed Pelvic Floor Muscle Training (PFMT) in Treatment and Prevention of POP (POP Study)
Conditions: Uterine Prolapse;   Bladder Diseases;   Cystocele;   Rectocele
Intervention: Behavioral: Pelvic floor muscle training
11 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
12 Recruiting Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Conditions: Anxiety Disorder;   Depression;   Fatigue;   Leydig Cell Tumor;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Pain;   Peritoneal Carcinomatosis;   Pseudomyxoma Peritonei;   Recurrent Breast Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Gestational Trophoblastic Tumor;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Recurrent Uterine Sarcoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: psychosocial assessment and care;   Behavioral: behavioral intervention;   Other: cognitive intervention;   Other: educational intervention
13 Completed Uterine Papillary Serous Cancer (UPSC) Trial
Condition: Uterine Cancer
Intervention: Drug: Paclitaxel, Carboplatin
14 Recruiting Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer;   Uterine Cervical Cancer
Interventions: Drug: Filgrastim;   Drug: Paclitaxel;   Drug: Carboplatin
15 Completed Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix
Conditions: Cervical Intraepithelial Neoplasia;   Cervix Cancer;   Cervical Dysplasia;   CIN;   Human Papillomavirus
Intervention: Device: NIRIS 1300e
16 Not yet recruiting Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, and Urologic Cancers
Conditions: Healthy, no Evidence of Disease;   Localized Transitional Cell Cancer of the Renal Pelvis and Ureter;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Psychosocial Effects of Cancer and Its Treatment;   Recurrent Bladder Cancer;   Recurrent Cervical Cancer;   Recurrent Colon Cancer;   Recurrent Gastric Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Pancreatic Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Recurrent Uterine Sarcoma;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage II Bladder Cancer;   Stage II Renal Cell Cancer;   Stage II Urethral Cancer;   Stage IIA Cervical Cancer;   Stage IIA Colon Cancer;   Stage IIA Gastric Cancer;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIA Pancreatic Cancer;   Stage IIA Rectal Cancer;   Stage IIA Uterine Sarcoma;   Stage IIB Cervical Cancer;   Stage IIB Colon Cancer;   Stage IIB Gastric Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIB Pancreatic Cancer;   Stage IIB Rectal Cancer;   Stage IIB Uterine Sarcoma;   Stage IIC Colon Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Ovarian Germ Cell Tumor;   Stage IIC Rectal Cancer;   Stage III Bladder Cancer;   Stage III Pancreatic Cancer;   Stage III Renal Cell Cancer;   Stage III Urethral Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Gastric Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Rectal Cancer;   Stage IIIA Uterine Sarcoma;   Stage IIIB Cervical Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Gastric Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Rectal Cancer;   Stage IIIB Uterine Sarcoma;   Stage IIIC Colon Cancer;   Stage IIIC Gastric Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Rectal Cancer;   Stage IIIC Uterine Sarcoma;   Stage IV Bladder Cancer;   Stage IV Gastric Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IV Urethral Cancer;   Stage IVA Cervical Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Uterine Sarcoma;   Stage IVB Cervical Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer;   Stage IVB Uterine Sarcoma;   Ureter Cancer
Interventions: Other: educational intervention;   Behavioral: telephone-based intervention;   Procedure: quality-of-life assessment;   Other: questionnaire administration
17 Active, not recruiting Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Conditions: Fallopian Tube Cancer;   Female Reproductive Cancer;   Ovarian Carcinosarcoma;   Ovarian Sarcoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Uterine Sarcoma;   Stage III Ovarian Epithelial Cancer;   Stage III Uterine Sarcoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma;   Uterine Leiomyosarcoma
Interventions: Drug: ziv-aflibercept;   Other: laboratory biomarker analysis;   Other: pharmacological study
18 Recruiting Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Uterine Cancer
Interventions: Drug: Olaparib;   Drug: Carboplatin;   Drug: Paclitaxel
19 Recruiting Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Condition: Uterine Cervical Neoplasms
Intervention: Radiation: Tomotherapy
20 Active, not recruiting Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Sarcoma
Interventions: Other: communication analysis;   Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years